Ty Gluckman, MD, explains the main points of the American College of Cardiology (ACC) expert consensus on the cardiovascular consequences stemming from a COVID-19 infection.

Leslee Shaw, PhD, director of the Blavatnik Family Women’s Health Research Institute at Mount Sinai Hospital in New York and former president of the Society of Cardiovascular Computed Tomography (SCCT) and the American Society of Nuclear Cardiology (ASNC), explains the role of cardiac computed tomography (CT) in the recent 2021 chest pain guidelines.

Fry joined us for an exclusive interview, discussing lessons learned during the pandemic, some key ways to address physician burnout and much more. 

Over the past few weeks, members of ASNC’s Health Policy Committee have held meetings with their members of Congress.

The grants went to 11 different research teams in the United States and are expected to fund these projects for three years.

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19. 

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.